St. Jude Medical (STJ) Reports In-Line Q4 EPS; Issues Light Q1 EPS Outlook

St. Jude Medical (NYSE: STJ) reported Q4 EPS of $1.03, in-line with the analyst estimate of $1.03. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.44 billion.

St. Jude Medical sees Q1 2015 EPS of $0.90-$0.92, versus the consensus of $0.97.

For earnings history and earnings-related data on St. Jude Medical (STJ) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Citi sees Birkenstock EPS beat, guidance lift on FX and lower share count
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance